Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation

被引:74
作者
Cheng, Hsien-Jen [2 ]
Lei, Huan-Yao [1 ]
Lin, Chiou-Feng [3 ]
Luo, Yueh-Hsia [2 ]
Wan, Shu-Wen [2 ]
Liu, Hsiao-Sheng [1 ]
Yeh, Trai-Ming [4 ]
Lin, Yee-Shin [1 ,5 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 701, Taiwan
[4] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan
[5] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan
关键词
Dengue virus; Nonstructural protein 1; Protein disulfide isomerase; Antibodies; Platelet aggregation; Cross-reactive epitope; HUMAN ENDOTHELIAL-CELLS; DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; CROSS-REACT; INFECTION; THROMBOCYTOPENIA; ACTIVATION; SURFACE; IMMUNOPATHOGENESIS; GLYCOPROTEIN;
D O I
10.1016/j.molimm.2009.08.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hemorrhagic syndrome is a hallmark of severe dengue diseases. We previously suggested a mechanism of molecular mimicry in which antibodies against dengue virus (DV) nonstructural protein 1 (NS1) cross-react with platelets. In the present study. we demonstrate that protein disulfide isomerase (PDI) on the platelet surface is recognized by anti-DV NS1 antibodies. Anti-DV NS1 obtained from hyperimmunized mouse sera inhibited PDI activity and platelet aggregation, and both inhibitory effects were prevented when anti-DV NS1 antibodies were preabsorbed with PDI Anti-PDI antibodies bound to a peptide consisting of amino acid residues 311-330 (P311-330) of NS1. This peptide was a predicted epitope analyzed by homologous sequence alignments between DV NS1 and PDI The platelet binding activities of anti-PDI and anti-DV NS1 antibodies were both reduced by P311-330 preabsorption. Similar to the findings using anti-DV NS1, antibodies against P311-330 bound to PDI and platelets, followed by inhibition of PDI activity and platelet aggregation. Furthermore, the cross-reactivity of dengue hemorrhagic fever patient sera with platelets was reduced when patient sera were preabsorbed with PDI or P311-330. Dengue hemorrhagic fever patient sera also inhibited platelet aggregation, while PDI or P311-330 reduced this inhibitory effect. In conclusion, anti-DV NS1 antibodies cross-react with PDI on platelet surface causing inhibition of platelet aggregation, which may provide implications in dengue disease pathogenesis. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 50 条
[31]   Antibodies from dengue patient sera cross-react with endothelial cells and induce damage [J].
Lin, CF ;
Lei, HY ;
Shiau, AL ;
Liu, CC ;
Liu, HS ;
Yeh, TM ;
Chen, SH ;
Lin, YS .
JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (01) :82-90
[32]   Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide [J].
Lin, CF ;
Lei, HY ;
Shiau, AL ;
Liu, HS ;
Yeh, TM ;
Chen, SH ;
Liu, CC ;
Chiu, SC ;
Lin, YS .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :657-664
[33]  
Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2<143::AID-JMV1009>3.0.CO
[34]  
2-L
[35]   Patient and Mouse Antibodies against Dengue Virus Nonstructural Protein 1 Cross-React with Platelets and Cause Their Dysfunction or Depletion [J].
Lin, Chiou-Feng ;
Lei, Huan-Yao ;
Liu, Ching-Chuan ;
Liu, Hsiao-Sheng ;
Yeh, Trai-Ming ;
Anderson, Robert ;
Lin, Yee-Shin .
AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2008, 4 (01) :69-75
[36]  
LITTAUA R, 1990, J IMMUNOL, V144, P3183
[37]  
MADY BJ, 1991, J IMMUNOL, V147, P3139
[38]   Protein disulphide isomerase in platelet function [J].
Manickam, Nagaraj ;
Sun, Xiuhua ;
Li, Mengru ;
Gazitt, Yair ;
Essex, David W. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (02) :223-229
[39]  
Mathew A, 1999, J IMMUNOL, V162, P5609
[40]   ANTIBODY-DEPENDENT ENHANCEMENT OF INFECTION AND THE PATHOGENESIS OF VIRAL DISEASE [J].
MORENS, DM .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (03) :500-512